2010 Sixth International Conference on Intelligent Information Hiding and Multimedia Signal Processing 2010
DOI: 10.1109/iihmsp.2010.8
|View full text |Cite
|
Sign up to set email alerts
|

Possible Disease-Link Genetic Pathways Constructed by Hierarchical Clustering and Conditional Probabilities of Ovarian Carcinoma Microarray Data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…ADCY6 encodes adenylyl cyclase 6, which is a membrane-associated enzyme catalyzing the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). The differential expression of this gene has also been reported in breast cancer [ 20 ] and ovarian carcinoma by microarray analysis [ 21 ]. By microarray analysis, ADCY6 expression was found to be decreased by 2-fold more in the 81-fold gemcitabine-resistant variant MiaPaCa2-RG than in the gemcitabine-sensitive cell line MiaPaCa2 [ 22 ], suggesting that high ADCY6 expression is associated with gemcitabine sensitivity.…”
Section: Discussionmentioning
confidence: 94%
“…ADCY6 encodes adenylyl cyclase 6, which is a membrane-associated enzyme catalyzing the formation of the secondary messenger cyclic adenosine monophosphate (cAMP). The differential expression of this gene has also been reported in breast cancer [ 20 ] and ovarian carcinoma by microarray analysis [ 21 ]. By microarray analysis, ADCY6 expression was found to be decreased by 2-fold more in the 81-fold gemcitabine-resistant variant MiaPaCa2-RG than in the gemcitabine-sensitive cell line MiaPaCa2 [ 22 ], suggesting that high ADCY6 expression is associated with gemcitabine sensitivity.…”
Section: Discussionmentioning
confidence: 94%